Aim Elevated levels of sterol regulatory element-binding protein-1 (SREBP-1) have been found in endometrial cancer (EC), suggesting that it is essential to the development of EC. Obesity and diabetes have been established as known risk factors of EC, while SREBF-1 gene polymorphisms have also been found to be associated with obesity and type II diabetes. Therefore, we hypothesize that single nucleotide polymorphism (SNP) in SREBF-1 gene may be associated with increased risk of EC. Method We analyzed the sequence of SREBF-1 in tissue samples from 30 EC cases and 6 benign controls using high throughput method. Based on the primary results, we selected one SNP (rs2297508) as a genetic marker to conduct a hospital-based case-control study with 139 EC cases and 129 benign controls. The samples were examined under the microscope to determine their histopathology prior to the SNP analysis using RT-PCR. Results Through sequence analysis, we found 10 SNPs of SREBF-1 associated with EC, including 3 new SNPs. Fourteen percent of EC showed the rs2297508 SNP with C allele, while only 7% had the C allele was present in benign controls (p = 0.027, OR = 1.983). Additionally, the C allele was associated with cancer differentiation (p<0.05) and the depth of myometrial invasion (p<0.05). Conclusion Our study indicates that SNP (rs2297508) of SREBF-1 may serve as a genetic predisposition factor for the development of EC and screening of such genetic marker may be helpful in its early detection.
Siegel R, Naishadham D, Jemal A (2013) Cancer statistics 2013. CA Cancer J. Clin 63: 11–30. doi: 10.3322/caac.21166
[3]
Weiss JM, Saltzman BS, Doherty JA, Voigt LF, Chen C, et al. (2006) Risk factors for the incidence of endometrial cancer according to the aggressiveness of disease. Am J Epidemiol 164: 56–62. doi: 10.1093/aje/kwj152
[4]
Wang PH, Yi YC, Tsai HT, Tee YT, Ko JL, et al. (2010) Significant association of genetic polymorphism of human nonmetastatic clone 23 type 1 gene with an increased risk of endometrial cancer. Gynecol Oncol 119: 70–75. doi: 10.1016/j.ygyno.2010.06.013
[5]
Su CK, Yeh KT, Yeh CB, Wang PH, Ho ES, et al. (2011) Genetic Polymorphism of the Plasminogen Activator Inhibitor-1 is Associated With an Increased Risk of Endometrial Cancer. J Surg Oncol 104: 755–759. doi: 10.1002/jso.22035
[6]
O'Mara TA, Fahey P, Ferguson K, Marquart L, Lambrechts D, et al. (2011) Progesterone receptor gene variants and risk of endometrial cancer. Carcinogenesis 32: 331–335. doi: 10.1093/carcin/bgq263
[7]
Brown MS, Goldstein JL (1997) The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 89: 331–340. doi: 10.1016/s0092-8674(00)80213-5
[8]
Horton JD, Goldstein JL, Brown MS (2002) SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. Invest 109: 1125–1131. doi: 10.1172/jci0215593
[9]
Claudio R, Santos AS (2012) Lipid metabolism in cancer. The Febs journal 279: 2610–2623. doi: 10.1111/j.1742-4658.2012.08644.x
[10]
Menendez JA, Lupu R (2007) Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer 7: 763–777. doi: 10.1038/nrc2222
[11]
Horton JD (2002) Sterol regulatory element-binding proteins: transcriptional activators of lipid synthesis. Biochem Soc Trans 30: 1091–1095. doi: 10.1042/bst0301091
[12]
Huang WC, Li X, Liu J, Lin J, Chung LW (2012) Activation of androgen receptor, lipogenesis, and oxidative stress converged by SREBP-1 is responsible for regulating growth and progression of prostate cancer cells. Mol Cancer Res 10: 133–142. doi: 10.1158/1541-7786.mcr-11-0206
[13]
Yang Yu, Morin PJ, Han WF, Chen T, Bornman DM, et al. (2003) Regulation of fatty acid synthase expression in breast cancer by sterol regulatory element binding protein-1c. Exp Cell Res 282: 132–137. doi: 10.1016/s0014-4827(02)00023-x
[14]
Rashid A, Pizer ES, Moga M, Milgraum LZ, Zahurak M, et al. (1997) Elevated expression of fatty acid synthase and fatty acid synthetic activity in colorectal neoplasia. Am J Pathol 150: 201–208.
[15]
Wang Q, Zhang WY, Ye LH, Zhang XD (2010) A mutant of HBx (HBxΔ127) promotes hepatoma cell growth via sterol regulatory element binding protein 1c involving 5-lipoxygenase. Acta Pharmacologica Sin 31: 367–374. doi: 10.1038/aps.2010.5
[16]
Jeon TI, Osborne TF (2012) SREBPs: metabolic integrators in physiology and metabolism. Trends Endocrinol Metab 23: 65–72. doi: 10.1016/j.tem.2011.10.004
[17]
Kaaks R, Lundin E, Rinaldi S, Manjer J, Biessy C, et al. (2002) Prospective study of IGF-I, IGF-binding proteins, and breast cancer risk, in northern and southern Sweden. Cancer Causes Control 13: 307–316. doi: 10.1023/a:1015270324325
[18]
Li W, Tai Y, Zhou J, Gu W, Bai Z, et al. (2012) Repression of endometrial tumor growth by targeting SREBP1 and lipogenesis. Cell Cycle 11: 2348–58. doi: 10.4161/cc.20811
[19]
Krycer JR, Sharpe LJ, Luu W, Brown AJ (2010) The Akt-SREBP nexus: cell signaling meets lipid metabolism. Trends Endocrinol. Metab 21: 268–276. doi: 10.1016/j.tem.2010.01.001
[20]
Wei Shao, Peter J (2012) Espenshade. Expanding Roles for SREBP in Metabolism. Cell Metabolism 16: 414–419. doi: 10.1016/j.cmet.2012.09.002
[21]
Modesitt SC, Geffel DL, Via J, L Weltman A (2012) Morbidly obese women with and without endometrial cancer: are there differences in measured physical fitness, body composition, or hormones? Gynecol Oncol 124: 431–436. doi: 10.1016/j.ygyno.2011.11.013
[22]
Nagasaki S, Miki Y, Akahira J, Suzuki T, Sasano H (2009) Transcriptional regulation of 17beta-hydroxysteroid dehydrogenase type 12 by SREBP-1. Mol Cell Endocrinol 307: 163–168. doi: 10.1016/j.mce.2009.04.002
[23]
Luu-The V, Tremblay P, Labrie F (2006) Characterization of type 12 17beta-hydroxysteroid dehydrogenase, an isoform of type 3 17beta-hydroxysteroid dehydrogenase responsible for estradiol formation in women. Mol Endocrinol 20: 437–443. doi: 10.1210/me.2005-0058
[24]
Eberlé D, Clément K, Meyre D, Sahbatou M, Vaxillaire M, et al. (2004) SREBF-1 Gene Polymorphisms Are Associated With Obesity and Type 2 Diabetes in French Obese and Diabetic Cohorts. Diabetes 53: 2153–2157. doi: 10.2337/diabetes.53.8.2153
[25]
Liu JX, Liu J, Li PQ, Xie XD, Guo Q, et al. (2008) Association of sterol regulatory element-binding protein-1c gene polymorphism with type 2 diabetes mellitus, insulin resistance and blood lipid levels in Chinese population. Diabetes Res Clin Pract 82: 42–47. doi: 10.1016/j.diabres.2008.06.017
[26]
Campa D, McKay J, Sinilnikova O, Hüsing A, Vogel U, et al. (2009) Genetic variation in genes of the fatty acid synthesis pathway and breast cancer risk. Breast Cancer Res Treat 118: 565–574. doi: 10.1007/s10549-009-0347-8
